226 related articles for article (PubMed ID: 6811295)
1. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
Brammer JP; Kerecsen L; Maguire MH
Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
[TBL] [Abstract][Full Text] [Related]
2. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
3. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Maguire MH; Csonka-Khalifah L
Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
5. Acetal phosphatidic acids: novel platelet aggregating agents.
Brammer JP; Maguire MH; Walaszek EJ; Wiley RA
Br J Pharmacol; 1983 May; 79(1):157-66. PubMed ID: 6871540
[TBL] [Abstract][Full Text] [Related]
6. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
7. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
8. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
10. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
11. Beclobrinic acid--a new hypolipidemic agent--inhibits in vitro human platelet activation by blocking prostaglandin synthesis.
Anwer K; Gabis J; Romstedt K; Gojer C; Huzoor-Akbar
Life Sci; 1985 Jul; 37(1):63-70. PubMed ID: 3925267
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
Hecker M; Ullrich V; Fischer C; Meese CO
Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
[TBL] [Abstract][Full Text] [Related]
14. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
Busse WD; Seuter F
Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
[TBL] [Abstract][Full Text] [Related]
15. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
16. Influence of epinephrine on the aggregation response of aspirin-treated platelets.
Rao GH; Johnson GJ; White JG
Prostaglandins Med; 1980 Jul; 5(1):45-58. PubMed ID: 7403340
[TBL] [Abstract][Full Text] [Related]
17. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
Burch JW; Burch PT
Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
[TBL] [Abstract][Full Text] [Related]
18. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
19. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
Le Breton GC; Venton DL; Enke SE; Halushka PV
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.
Teng CM; Jy W; Ouyang C
Toxicon; 1984; 22(3):463-70. PubMed ID: 6474495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]